The Epigenetics of complex diseases and traits research group is affiliated at the Institute for Molecular Medicine Finland (FIMM), the University of Helsinki, Finland.
Institute for Molecular Medicine Finland (FIMM) is an international research institute in Helsinki focusing on human genomics and personalized medicine. FIMM integrates molecular medicine research, Technology Centre and Biobanking Infrastructures “under one roof” and thereby promotes translational research and adoption of personalized medicine in health care. FIMM is part of the Nordic EMBL Partnership for Molecular Medicine, composed of the European Molecular Biology Laboratory (EMBL) and the centers for molecular medicine in Norway, Sweden and Denmark. At the national level, FIMM is a joint research institute of the University of Helsinki (primary host), the Hospital District of Helsinki and Uusimaa, the National Institute for Health and Welfare, and VTT Technical Research Centre of Finland.
The University of Helsinki is one of the best multidisciplinary research universities in the world. The high-quality research carried out by the university creates new knowledge for educating diverse specialists in various fields, and for utilization in social decision-making and the business sector.
The Faculty of Medicine has a strong research tradition ranging from basic biological research to clinical applications. The Faculty ranks fifth among European universities based on the citation index for clinical medicine.
The Finnish Twin Cohort Study is a core resource of the Department of Public Health. The Finnish Twin Cohort comprises a series of three longitudinal cohorts of a total of 19 388 Finnish twin pairs. Several waves of data on behavioral and lifestyle traits as well as health status are available from these pairs. The topics of research are primarily within the area of major risk factors for different diseases such as diet, physical activity, obesity and substance use.